Literature DB >> 29243115

Activity of taurolidine gels on ex vivo periodontal biofilm.

Luca Pirracchio1, Aline Joos1, Nina Luder1, Anton Sculean1, Sigrun Eick2.   

Abstract

OBJECTIVES: The purpose of this study is to evaluate the activity of two different taurolidine (TAU) gels in comparison with a 0.2% chlorhexidine (CHX) gel on an ex vivo subgingival biofilm.
MATERIAL AND METHODS: Subgingival including supragingival biofilm samples from periodontitis patients were cultured for 10 days, before TAU 1% and TAU 3% gels and CHX gel were applied for 10 min and thereafter diluted with nutrient media to 10% for 50 min. One third of the samples were analyzed for bacterial counts, biofilm quantity, and biofilm metabolic activity. In the two other thirds, 90% of the nutrient media were replaced and biofilms were incubated for 23 h. The second third was analyzed in the same way as before. In the third part, patients' microorganisms were added again and incubated for additional 24 h to allow reformation of biofilm before proceeding to analysis.
RESULTS: Decrease of bacterial counts in biofilms was highest following application of TAU 3% after 60 min (0.87 log10 cfu, corresponding 86.5%), 24 and 48 h (reformation of biofilms), respectively. All antimicrobials reduced biofilm quantity after 24 h (each p < 0.05) and following reformation of biofilms (each p < 0.01). Metabolic activity in biofilms was decreased at 60 min (each p < 0.05) and at 24 h (each p < 0.01) after application of TAU gels, while the activity of the reformed biofilm was lower after application of all evaluated antimicrobials (each p < 0.01) than in the control group (e.g., without exposure to antimicrobials).
CONCLUSION: The antimicrobial activity of taurolidine gels clearly depends on its taurolidine concentration. A high concentrated taurolidine gel is equally active or even superior to 0.2% chlorhexidine gel. However, the activity of antimicrobials is limited in a complex established biofilm and underlines the pivotal role of mechanical biofilm disruption. CLINICAL RELEVANCE: Within their limits, the data suggest that TAU 3% gel might represent a potential alternative to 0.2% chlorhexidine gel.

Entities:  

Keywords:  Antimicrobial; Biofilm; Periodontal therapy

Mesh:

Substances:

Year:  2017        PMID: 29243115     DOI: 10.1007/s00784-017-2297-6

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  50 in total

1.  Integrity of proteins in human saliva after sterilization by gamma irradiation.

Authors:  Stefan Ruhl; Pereshia Berlenbach; Sabine Langenfelder; Dagmar Hörl; Norbert Lehn; Karl-Anton Hiller; Gottfried Schmalz; Helmut Durchschlag
Journal:  Appl Environ Microbiol       Date:  2010-12-10       Impact factor: 4.792

2.  Comparison of real-time polymerase chain reaction and DNA-strip technology in microbiological evaluation of periodontitis treatment.

Authors:  Sigrun Eick; Anna Straube; Arndt Guentsch; Wolfgang Pfister; Holger Jentsch
Journal:  Diagn Microbiol Infect Dis       Date:  2011-01       Impact factor: 2.803

3.  An in vitro biofilm model of subgingival plaque.

Authors:  C Walker; M J Sedlacek
Journal:  Oral Microbiol Immunol       Date:  2007-06

4.  Antibiotic resistance in an in vitro subgingival biofilm model.

Authors:  M J Sedlacek; C Walker
Journal:  Oral Microbiol Immunol       Date:  2007-10

5.  Antibacterial effect of N-acetylcysteine and taurolidine on planktonic and biofilm forms of Enterococcus faecalis.

Authors:  Ayca Tuba Ulusoy; Elif Kalyoncuoğlu; Ahu Reis; Zafer C Cehreli
Journal:  Dent Traumatol       Date:  2015-10-29       Impact factor: 3.333

6.  The mode of antibacterial action of some 'masked' formaldehyde compounds.

Authors:  M J Gidley; J K Sanders; E R Myers; M C Allwood
Journal:  FEBS Lett       Date:  1981-05-18       Impact factor: 4.124

7.  Efficacy of taurolidine against periodontopathic species--an in vitro study.

Authors:  Sigrun Eick; Sabrina Radakovic; Wolfgang Pfister; Sandor Nietzsche; Anton Sculean
Journal:  Clin Oral Investig       Date:  2011-05-24       Impact factor: 3.573

8.  Mechanisms underlying chlorhexidine-induced cytotoxicity.

Authors:  E Hidalgo; C Dominguez
Journal:  Toxicol In Vitro       Date:  2001 Aug-Oct       Impact factor: 3.500

9.  Subgingival chlorhexidine varnish administration as an adjunct to same-day full-mouth root planing. II. Microbiological observations.

Authors:  Jan Cosyn; Mehran Moradi Sabzevar
Journal:  J Periodontol       Date:  2007-03       Impact factor: 6.993

Review 10.  Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response.

Authors:  George Hajishengallis
Journal:  Trends Immunol       Date:  2013-10-23       Impact factor: 16.687

View more
  6 in total

Review 1.  Biofilms: Formation, Research Models, Potential Targets, and Methods for Prevention and Treatment.

Authors:  Yajuan Su; Jaime T Yrastorza; Mitchell Matis; Jenna Cusick; Siwei Zhao; Guangshun Wang; Jingwei Xie
Journal:  Adv Sci (Weinh)       Date:  2022-08-28       Impact factor: 17.521

2.  Taurolidine Acts on Bacterial Virulence Factors and Does Not Induce Resistance in Periodontitis-Associated Bacteria-An In-Vitro Study.

Authors:  Sabrina Radakovic; Nicola Andreoli; Simon Schmid; Sandor Nietzsche; Jürg Zumbrunn; Anton Sculean; Sigrun Eick
Journal:  Antibiotics (Basel)       Date:  2020-04-07

3.  Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications.

Authors:  Howard H Wang; Hsi-Ming Lee; Veena Raja; Wei Hou; Vincent J Iacono; Joseph Scaduto; Francis Johnson; Lorne M Golub; Ying Gu
Journal:  J Exp Pharmacol       Date:  2019-01-23

4.  The In-Vitro Activity of a Cold Atmospheric Plasma Device Utilizing Ambient Air against Bacteria and Biofilms Associated with Periodontal or Peri-Implant Diseases.

Authors:  Gert Jungbauer; Leandro Favaro; Steffen Müller; Anton Sculean; Sigrun Eick
Journal:  Antibiotics (Basel)       Date:  2022-05-31

5.  In Vitro Evaluation of Antimicrobial Activity of Minocycline Formulations for Topical Application in Periodontal Therapy.

Authors:  Jan-Luca Schmid; Martin Kirchberg; Sandra Sarembe; Andreas Kiesow; Anton Sculean; Karsten Mäder; Mirko Buchholz; Sigrun Eick
Journal:  Pharmaceutics       Date:  2020-04-13       Impact factor: 6.321

6.  A new anabolic compound, LLP2A-Ale, reserves periodontal bone loss in mice through augmentation of bone formation.

Authors:  Min Jiang; Lixian Liu; Ruiwu Liu; Kit S Lam; Nancy E Lane; Wei Yao
Journal:  BMC Pharmacol Toxicol       Date:  2020-11-13       Impact factor: 2.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.